Conducted a comprehensive literature-driven investigation into chimeric antigen receptor (CAR) design strategies for macrophage-based cancer immunotherapy. Systematically evaluated and compared a wide range of candidate CAR constructs to identify the optimal dual-targeting configuration, ultimately selecting a combination of anti-CD47 and anti-HER2 single-chain variable fragment (scFv) binding domains. The rationale centred on simultaneously blocking the "don't eat me" CD47-SIRPα inhibitory checkpoint to restore phagocytic activity, while directing macrophage cytotoxicity toward HER2-overexpressing tumor cells. Researched lipid nanoparticle (LNP) delivery systems modelled on clinical-grade formulations to enable in vivo mRNA transfection of tumor-associated macrophages without ex vivo manipulation. Synthesized findings into a theoretical framework that was presented at the MURC 2025 conference and published as an abstract in the Canadian Undergraduate Research Journal, demonstrating both scientific rigour and effective scientific communication.
Contribution to Project (2)
Contributed to a machine learning research project focused on endometriosis detection and classification using clinical and imaging data. Designed and implemented a complete end-to-end ML pipeline, beginning with exploratory data analysis (EDA) to identify class imbalances, missing values, and feature distributions. Applied data preprocessing strategies including normalization, one-hot encoding, and SMOTE-based oversampling to address class imbalance inherent to medical datasets. Established and evaluated a suite of baseline models encompassing logistic regression, decision trees, k-nearest neighbours (KNN), and support vector machines (SVM) to benchmark predictive performance across metrics including accuracy, precision, recall, F1-score, and AUC-ROC. Performed systematic hyperparameter tuning using grid search with stratified k-fold cross-validation to optimize model generalization and prevent overfitting on limited clinical data. Investigated ensemble methods including Random Forest and Gradient Boosting (XGBoost, LightGBM) to improve classification robustness. Conducted feature importance analysis using SHAP (SHapley Additive exPlanations) values to identify clinically interpretable predictors, contributing to translational insight into endometriosis biomarkers. Evaluated model calibration and decision threshold optimization to maximize clinical utility, balancing sensitivity and specificity for a high-stakes diagnostic context. Documented all experimental results in structured notebooks using Jupyter, with reproducible pipelines and version-controlled code.
Contribution to Project (3)
Led the development of a deep learning pipeline for sarcopenia detection and muscle mass quantification from medical imaging data (CT/MRI). Personally contributed to the creation of a custom annotated dataset by manually segmenting and labeling muscle masks across a large cohort of medical images using clinical annotation tools, ensuring high inter-rater reliability through iterative quality checks. Designed and trained multiple convolutional neural network (CNN) architectures — including U-Net and modified ResNet-based segmentation models — on these self-annotated masks to automate skeletal muscle cross-sectional area (CSA) measurement, a key biomarker for sarcopenia diagnosis. Conducted rigorous model benchmarking across architectures by evaluating Dice coefficient, Intersection over Union (IoU), sensitivity, and specificity on held-out validation sets. Performed multi-round hyperparameter optimization using techniques including learning rate scheduling, dropout regularization, batch normalization tuning, and data augmentation strategies (random flipping, rotation, elastic deformation) to reduce overfitting and improve generalization across patient demographics. Achieved a dramatic reduction in radiologist processing time — from approximately 30 minutes per scan down to 0.1 seconds — by replacing manual segmentation workflows with the trained automated model, representing a clinically significant efficiency gain. Integrated the inference pipeline into a deployable format to support radiologist workflow integration, enabling scalable sarcopenia screening in clinical environments. Contributed to the technical documentation and validation of model performance for potential translational and regulatory consideration.
What I'm looking for
Sector(s) of Interest
IndustryAcademia
Role(s) of Interest
BioinformaticianLab TechnicianStaff Scientist
Research Fields & Keywords
3d genomics3d tumor modelsagentic AIAIAi in pharmacy and biotechnologyapplied mathematicscancer biologyCancer Epigeneticsmacrophagemedical devices and medtechradiology
Supervision preferences
I prefer a mix of hands on check-in, and some time to understand and comprehend tasks. I like an environment where people are challenged to think, but resources are provided from a time to time basis, to improve their work.
Career Goals
Industry ResearchStart-up
Countries of Interest
AustraliaAustriaCanadaGermanySwitzerlandUnited Kingdom (UK)United States (US)